Excitement is building around a new weight loss drug, CagriSema, which is expected to surpass the effects of popular drugs ...

While Novo Nordisk says CagriSema will help users lose up to 25% of weight, duration will be clear when final results of its ...

The costs for 806 patients with overweight or obesity and heart failure were analyzed in one study. For those patients, the average total medical costs dropped from $29,654 before treatment began to ...

The ‘Ozempic drug,’ semaglutide, has been found to reduce moderately severe pain caused by knee osteoarthritis and improve ...

Losing weight on GLP-1 drugs like Ozempic isn't guaranteed. Experts reveal how to tell if yours isn't working and the next steps you should take to reach your weight loss goals.

Eli Lilly and Co.’s recent decision to drop development at phase II of PD-1 agonist peresolimab in rheumatoid arthritis (RA) because of an inadequate benefit-risk profile brought further attention to ...

Semaglutide, popularly known as Ozempic, belongs to this class of drugs and is known ... The SELECT trial tracked more than 17,600 people, aged 45 or older, as they were given either 2.4 mg of ...

Ten people have died and 100 have been hospitalized after taking pharmacy-made copycat versions of Ozempic, its manufacturer has revealed. These compounded weight loss drugs, which are often ...

Novo Nordisk on Wednesday nudged higher its profit outlook for the year as the drugmaker registered another quarter of strong sales of its weight-loss drugs. Novo Nordisk said its third-quarter ...

Advice for first-time home buyers from Money Box Live. DEC Middle East Humanitarian Appeal. Appeal to help those affected by the humanitarian crisis. Give via the DEC website.

News, views and features on today's stories in Parliament ...